Progress in the discovery and development of glutamate carboxypeptidase II inhibitors
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference93 articles.
1. l-glutamate as a central neurotransmitter: looking back;Watkins;Biochem. Soc. Trans.,2000
2. Amino acids are still as exciting as ever;Carpenter;Curr. Opin. Pharmacol.,2001
3. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?;Ikonomidou;Lancet Neurol.,2002
4. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?;Albensi;Am. J. Alzheimers Dis. Other Demen.,2004
5. The NMDA receptor complex: a long and winding road to therapeutics;Wood;IDrugs,2005
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glutamate carboxypeptidase II;Metalloenzymes;2024
2. 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry;Frontiers in Oncology;2023-09-27
3. Synthesis and Evaluation of 99mTc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography;Molecules;2023-06-29
4. A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2023-06
5. Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors;Journal of Chemical Information and Modeling;2023-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3